标题
Cannabinoids in Metabolic Syndrome and Cardiac Fibrosis
作者
关键词
-
出版物
CURRENT HYPERTENSION REPORTS
Volume 22, Issue 12, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-22
DOI
10.1007/s11906-020-01112-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
- (2020) Patryk Remiszewski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The therapeutic potential of second and third generation CB1R antagonists
- (2020) Resat Cinar et al. PHARMACOLOGY & THERAPEUTICS
- Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice
- (2020) Lesly Nava-Molina et al. Nutrition & Diabetes
- The association of cannabis use and cardiac dysrhythmias: a systematic review
- (2020) John R. Richards et al. CLINICAL TOXICOLOGY
- A Guide to Targeting the Endocannabinoid System in Drug Design
- (2020) Adam Stasiulewicz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
- (2020) Ewa Harasim-Symbor et al. MOLECULES
- Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association
- (2020) Robert L. Page et al. CIRCULATION
- Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues
- (2019) Inigo Ruiz de Azua et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice
- (2019) Vincenzo Micale et al. Frontiers in Pharmacology
- Cannabinoid-sensitive receptors in cardiac health and disease
- (2019) Sarah-Lena Puhl BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis
- (2019) Adela García-Martín et al. BIOCHEMICAL PHARMACOLOGY
- Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
- (2019) Ivonne Bazwinsky-Wutschke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
- (2019) Arulkumar Nagappan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid Receptor 1 Blockade Attenuates Obesity and Adipose Tissue Type 1 Inflammation Through miR-30e-5p Regulation of Delta-Like-4 in Macrophages and Consequently Downregulation of Th1 Cells
- (2019) Kathryn Miranda et al. Frontiers in Immunology
- Role of the endocannabinoidome in human and mouse atherosclerosis
- (2019) Fabiana Piscitelli et al. CURRENT PHARMACEUTICAL DESIGN
- Interplay of liver‐heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy
- (2019) Csaba Matyas et al. HEPATOLOGY
- Myocardial maladaptation to pressure overload in CB2 receptor-deficient mice
- (2019) Georg D. Duerr et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome
- (2019) Vincenzo Di Marzo et al. Nutrients
- Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity
- (2019) Belén Palomares et al. BIOCHEMICAL PHARMACOLOGY
- Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
- (2019) Laura Casares et al. Redox Biology
- Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers
- (2018) Andrey Postnov et al. CTS-Clinical and Translational Science
- Cannabinoid Type 1 Receptors Are Upregulated During Acute Activation of Brown Adipose Tissue
- (2018) Minna Lahesmaa et al. DIABETES
- Peripheral modulation of the endocannabinoid system in metabolic disease
- (2018) Nirajan Shrestha et al. DRUG DISCOVERY TODAY
- Enhanced endocannabinoid tone as a potential target of pharmacotherapy
- (2018) Marek Toczek et al. LIFE SCIENCES
- Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity
- (2018) Ines Valenta et al. JACC-Cardiovascular Imaging
- Cannabinoids, the Heart of the Matter
- (2018) Naghum Alfulaij et al. Journal of the American Heart Association
- Knockout of CNR1 prevents metabolic stress-induced cardiac injury through improving insulin resistance (IR) injury and endoplasmic reticulum (ER) stress by promoting AMPK-alpha activation
- (2018) Su-Juan Pei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Monoacylglycerol lipase (MAGL) as a promising therapeutic target
- (2018) Ana Gil-Ordóñez et al. BIOCHEMICAL PHARMACOLOGY
- EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis
- (2018) Adela García-Martín et al. BIOCHEMICAL PHARMACOLOGY
- Role of Cannabinoids in Obesity
- (2018) Francesca Rossi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New approaches and challenges to targeting the endocannabinoid system
- (2018) Vincenzo Di Marzo NATURE REVIEWS DRUG DISCOVERY
- CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes
- (2018) Eugene Chang et al. PLoS One
- VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity
- (2018) Belen Palomares et al. Scientific Reports
- Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors
- (2018) Dareen A. Youssef et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats
- (2018) Ewa Harasim-Symbor et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
- (2018) Aida Habib et al. GUT
- Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure via Sirt1/mTORC2 and AMPK Signaling
- (2018) Jie Liu et al. HEPATOLOGY
- CB2-deficiency is associated with a stronger hypertrophy and remodeling of the right ventricle in a murine model of left pulmonary artery occlusion
- (2018) Georg Daniel Duerr et al. LIFE SCIENCES
- Cardiovascular effects of marijuana
- (2018) Shereif Rezkalla et al. TRENDS IN CARDIOVASCULAR MEDICINE
- MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future
- (2017) Vincent Simon et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages
- (2017) Inigo Ruiz de Azua et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
- (2017) Pal Pacher et al. Nature Reviews Cardiology
- Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits
- (2017) Benjamin K. Lau et al. NEUROPHARMACOLOGY
- Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats
- (2017) Hai-Jing Sun et al. Oxidative Medicine and Cellular Longevity
- Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
- (2017) Gernot F. Grabner et al. PHARMACOLOGY & THERAPEUTICS
- An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
- (2017) Paula Morales et al. Frontiers in Pharmacology
- Decreasing CB 1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
- (2017) Tony Jourdan et al. Molecular Metabolism
- Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis, and Cardiac Function After Myocardial Infarction
- (2017) Michael Horckmans et al. CIRCULATION
- Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice
- (2016) Xiang Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Cardiac Fibrosis
- (2016) Joshua G. Travers et al. CIRCULATION RESEARCH
- Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation
- (2016) F. Rossi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation
- (2016) Wen-Shin Lee et al. MOLECULAR MEDICINE
- Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase
- (2016) Anne Kerbrat et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
- (2016) Carmen del Río et al. Scientific Reports
- Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects
- (2013) Linda E. Klumpers et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endogenous cannabinoid receptor CB1activation promotes vascular smooth-muscle cell proliferation and neointima formation
- (2013) Filippo Molica et al. JOURNAL OF LIPID RESEARCH
- Low brain CB1 receptor occupancy by a second generation CB1 receptor antagonist TM38837 in comparison with rimonabant in nonhuman primates: A PET study
- (2013) Akihiro Takano et al. SYNAPSE
- Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
- (2012) Sabine Steffens et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
- (2012) M. Rajesh et al. DIABETES
- An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
- (2012) John P. Huggins et al. PAIN
- Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion
- (2010) Sarah K Walsh et al. BRITISH JOURNAL OF PHARMACOLOGY
- The origin of fibroblasts and mechanism of cardiac fibrosis
- (2010) Guido Krenning et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
- (2010) Mohanraj Rajesh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation
- (2008) Mohanraj Rajesh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages
- (2008) Koichi Sugamura et al. CIRCULATION
- End of the line for cannabinoid receptor 1 as an anti-obesity target?
- (2008) Dan Jones NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now